United States · Biotechnology startup
United States · Moleculera Labs
A personalized medicine company and clinical laboratory focused on autoimmune neuropsychiatric disorders in children and adults.
Funding reportedLast round: Undisclosed round
What company datasets say Moleculera Labs raised
Funding, as reported
Reported in all$6.2Min dollars
Rounds4
Last roundUndisclosed round
Last round dateMay 2015
Investors listed5
Founders and team
From Moleculera Labs's own website and the SEC filings it signed: 4 on the team.
- Craig ShimasakiChief Executive Officer, President and Directori
- Fred HillerChief Financial Officeri
- Moleculera BiosciencesBoard Members & Advisors
- Sammi L. HillBoard Member
On the board, as filediDavid Thomison
On a portfolio page
Investors who name them
Each firm lists Moleculera Labs on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Moleculera Labs in front of investors. Or tell us what we have wrong.